Literature DB >> 22001636

Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.

Iain J Nixon1, Ian Ganly, Snehal G Patel, Frank L Palmer, Monica M Whitcher, Robert M Tuttle, Ashok Shaha, Jatin P Shah.   

Abstract

BACKGROUND: There remains controversy over the type of surgery appropriate for T1T2N0 well differentiated thyroid cancers (WDTC). Current guidelines recommend total thyroidectomy for all but the smallest lesions, despite previous evidence from large institutions suggesting that lobectomy provides similar excellent results. The objective of this study was to report our experience of T1T2N0 WDTC managed by either thyroid lobectomy or total thyroidectomy.
METHODS: Eight hundred eighty-nine patients with pT1T2 intrathyroid cancers treated surgically between 1986 and 2005 were identified from a database of 1810 patients with WDTC. Total thyroidectomy was carried out in 528 (59%) and thyroid lobectomy in 361 (41%) patients. Overall survival (OS), disease-specific survival (DSS) and recurrence-free survival (RFS) were determined by the Kaplan-Meier method. Factors predictive of outcome by univariate and multivariate analysis were determined using the log rank test and Cox proportional hazards method respectively.
RESULTS: With a median follow-up of 99 months, the 10-yr OS, DSS, and RFS for all patients were 92%, 99%, and 98% respectively. Univariate analysis showed no significant difference in OS by extent of surgical resection. Multivariate analysis showed that age over 45 yr and male gender were independent predictors for poorer OS, whereas T stage and type of surgery were not. Comparison of the thyroid lobectomy group and the total thyroidectomy group showed no difference in local recurrence (0% for both) or regional recurrence (0% vs 0.8%, P = .96).
CONCLUSION: Patients with pT1T2 N0 WDTC can be safely managed by thyroid lobectomy alone. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22001636     DOI: 10.1016/j.surg.2011.08.016

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  61 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  Surgical management of papillary thyroid carcinoma: an overview.

Authors:  Paolo Miccoli; Sohail Bakkar
Journal:  Updates Surg       Date:  2017-04-12

3.  Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients.

Authors:  Rajshri M Gartland; Carrie C Lubitz
Journal:  Ann Surg Oncol       Date:  2018-05-31       Impact factor: 5.344

Review 4.  Controversial Issues in Thyroid Cancer Management.

Authors:  R Michael Tuttle
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

5.  Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-up.

Authors:  R Michael Tuttle; Ali S Alzahrani
Journal:  J Clin Endocrinol Metab       Date:  2019-03-15       Impact factor: 5.958

6.  Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system.

Authors:  Ruyi Zhang; Mei Xu; Xiangxiang Liu; Miao Wang; Qiang Jia; Shen Wang; Xiangqian Zheng; Xianghui He; Chao Huang; Yaguang Fan; Heng Wu; Ke Xu; Dihua Li; Zhaowei Meng
Journal:  Endocrine       Date:  2021-04-06       Impact factor: 3.633

7.  Current management of papillary thyroid microcarcinoma in Canada.

Authors:  Mazin Merdad; Antoine Eskander; John De Almeida; Jeremy Freeman; Lorne Rotstein; Shereen Ezzat; Anna M Sawka; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-08-14

8.  Surgical approach and radioactive iodine therapy for small well-differentiated thyroid cancer.

Authors:  D P Momesso; F Vaisman; L S C Caminha; C H C N Pessoa; R Corbo; M Vaisman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

9.  Hemithyroidectomy for low-risk follicular carcinoma of the thyroid: results from a regional hospital.

Authors:  Tam-Lin Chow; Susanna Wai-Yin Tam; Chi-Yee Choi; Wilson Wai-Yin Kwan
Journal:  Singapore Med J       Date:  2017-12-07       Impact factor: 1.858

Review 10.  The impact of family history on non-medullary thyroid cancer.

Authors:  I J Nixon; C Suárez; R Simo; A Sanabria; P Angelos; A Rinaldo; J P Rodrigo; L P Kowalski; D M Hartl; M L Hinni; J P Shah; A Ferlito
Journal:  Eur J Surg Oncol       Date:  2016-08-11       Impact factor: 4.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.